ArticleFrontiers in oncology2022

Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma.

Margherita Nannini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.